The immunostimulatory activity of polysaccharides from Glycyrrhiza uralensis

• Main Authors: Adila Aipire, Mahepali Mahabati, Shanshan Cai, Xianxian Wei, Pengfei Yuan, Alimu Aimaier, Xinhui Wang, Jinyao Li
• Format: Article
• Language: English
• Published: PeerJ Inc. 2020-01-01
• Series: PeerJ
• Subjects: Glycyrrhiza uralensis polysaccharides; Dendritic cell; Maturation; Cytokine production; Migration; Signaling pathway
• Online Access: https://peerj.com/articles/8294.pdf

Background The enhancement of immunity is very important for immunocompromised patients such as cancer patients with radiotherapy or chemotherapy. Glycyrrhiza uralensis has been used as food and medicine for a long history. G. uralensis polysaccharides (GUPS) were prepared and its immunostimulatory effects were investigated. Methods Human monocyte-derived dendritic cells (DCs) and murine bone marrow-derived DCs were treated with different concentrations of GUPS. The DCs maturation and cytokine production were analyzed by flow cytometry and ELISA, respectively. Inhibitors and Western blot were used to study the mechanism of GUPS. The immunostimulatory effects of GUPS were further evaluated by naïve mouse model and immunosuppressive mouse model induced by cyclophosphamide. Results GUPS significantly promoted the maturation and cytokine secretion of human monocyte-derived DCs and murine bone marrow-derived DCs through TLR4 and down-stream p38, JNK and NF-κB signaling pathways. Interestingly, the migration of GUPS treated-DCs to lymph node was increased. In the mouse model, GUPS increased IL-12 production in sera but not for TNF-α. Moreover, GUPS ameliorated the side effect of cyclophosphamide and improved the immunity of immunosuppressive mice induced by cyclophosphamide. These results suggested that GUPS might be used for cancer therapy to ameliorate the side effect of chemotherapy and enhance the immunity.